drugset / Trial / NCT00968110

Xolair Treatment for Milk Allergic Children

NCT00968110

NaSingle-groupOpen-labelTreatment

Summary

This is a pilot feasibility study, using Xolair pretreatment for oral milk desensitization. The major assessment will be safety, and the investigators will evaluate for any type of reaction, including allergic reactions that occur during the course of the study.

Timeline

Start
2009-03
Primary completion
2017-04
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Omalizumab Monoclonal antibody

Indications